#2019-917Decree No. 2019-917 of August 30, 2019, on the Control of Drug Precursors
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The law sets rules for controlling the production and trade of drug precursors in France. It requires companies dealing with these substances to obtain licenses or registrations and outlines the conditions for granting, suspending, or withdrawing these approvals. The law mainly targets businesses involved in importing, exporting, or handling chemical precursors linked to drugs, with specific procedures for compliance.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Introduction of licensing and registration requirements for businesses handling drug precursors.
- Detailed procedures for granting, suspending, and withdrawing licenses and registrations.
- Specific compliance obligations for importing and exporting chemical precursors.
Obligations
What this law requires
Obtain approval (agrément) from the Minister of Industry for operations on Category 1 drug precursors, valid for a maximum of 3 years
Submit complete application for approval including required documentation; applicants have 60 working days for initial applications and 30 working days for renewals before silence is deemed rejection
Obtain written export authorization from the Minister of Industry (after customs consultation) before exporting Category 1 drug precursors to non-EU countries; 15 working day decision deadline applies
Obtain written import authorization from the Minister of Industry (after customs consultation) before importing Category 1 drug precursors from non-EU countries; 15 working day decision deadline applies
Register with the Minister of Industry if handling Category 2 drug precursors exceeding annual thresholds defined in Annex II of EU Regulation 273/2004; 60 working days for initial applications and 30 days for renewals before silence is deemed rejection